Ms. Brüls serves as Corporate Vice President, EMEACLA at Edwards Lifesciences Corporation, overseeing strategic operations, commercial growth, and market expansion across Europe, the Middle East, Africa, Canada, and Latin America. With more than 25 years of experience in the medical technology sector, she brings a proven track record of driving high-impact results in complex, multicultural environments. Her career began in clinical sales for cardiovascular devices at a major European medtech firm, where she quickly advanced to regional leadership roles, honing expertise in regulatory affairs, supply chain optimization, and team development. Prior to Edwards Lifesciences, Ms. Brüls held senior positions at global healthcare companies, including Vice President of International Markets at a leading structural heart innovator, where she spearheaded a 40% revenue increase in emerging markets through targeted partnerships and digital transformation initiatives. At Edwards, she has been instrumental in accelerating adoption of transcatheter heart valve technologies, achieving record market share gains in key EMEACLA territories and launching patient access programs that have benefited over 100,000 individuals annually. Her achievements include multiple industry awards, such as the MedTech Europe Leadership Excellence Award, recognizing her for fostering inclusive growth and innovation. Fluent in five languages and holding an MBA from INSEAD, Ms. Brüls is a passionate advocate for equitable healthcare access, guiding Edwards Lifesciences' EMEACLA strategy with a focus on sustainability, digital health integration, and collaboration with local stakeholders to address unmet needs in structural heart disease.